In this study, clinical isolates of Bordetella pertussis collected in Poland from 1960 to 16 2005 were analyzed by pulsed-field gel electrophoresis (PFGE) according to recommended 17 references. Among the 110 isolates from 1995-2005, 59 PFGE patterns were found, most of 18 which were different from those currently circulating in other EU countries for which data are 19 available. PFGE patterns of currently disseminating B. pertussis clones were found within 20 PFGE groups III and IV, as elsewhere in the EU, and in newly identified clusters A and C. Up 21 to 70%, 26%, and 4%, respectively, of the currently isolated strains in Poland harbored 22 ptxA1/prn1, ptxA1/prn2, ptxA1/prn3 allele combinations and most (82%) were found to be of 23 the Fim2 phenotype. Differences in the extent of heterogeneity estimated by PFGE typing in 24 B. pertussis populations circulating in Poland in comparison to other EU countries may be 25
38). Among many available methodologies capable of tracking genetic differences among 51
isolates, PFGE has been the chosen reference method for epidemiological surveys (2, 31), 52 being the most discriminatory (4). 53
A study published by the European research program for strain characterization and 54 surveillance, the EUpertstrain II project, found B. pertussis strains from Poland isolated in 55 1999 to 2004 to be different from those observed in seven other European countries using the 56 PFGE technique (19) . A study on a more representative number of isolates from Poland has 57 been suggested to confirm unique PFGE patterns observed in Poland. In this study, we 58 describe the B. pertussis strain population isolated in Poland from 1960-2005 with respect to 59 vaccine strains used for production of the national DTP vaccine performed with the PFGE 60 procedure according to EUpertstrain guidelines (44). The isolates were also characterized by 61 serotyping and sequencing of PCR-amplified fragments of pertussis toxin ptxA subunit and 62 pertactin genes. The goal of the study was to establish the extent of differences seen in 63 B. pertussis strains circulating in Poland in order to contribute to the characterization of 64 B. pertussis strains circulating in Europe. 65
MATERIALS AND METHODS 66
Collection of strains. In total, 148 B. pertussis strains including 139 clinical isolates, 67 six historical (A/63, 21/60, 7/60, 25593/65, 1326/62, 60623/67) and three current (606/67, 68 PFGE profiles typical for group I (represented by 18323) and group II (represented by 99 Tohama I) were not found among the 139 clinical isolates and were related to other groups 100 at the levels of 62% and 70%, respectively. 101
The relatedness levels among the strains classified into groups III, IVα, IVβ, IVγ, and 102 V were found to be 88%, 93%, 92%, 89%, and 100%, respectively. For the newly identified 103 clusters A, B, and C, relatedness achieved values of 89%, 89%, and 87%, respectively. 104
In and prn3 alleles were found among 26% and 4% of strains, respectively (Table 3) . 137
As much as 38%, 38%, and 24% of the strains isolated in the period from 1960 to 138 1977 expressed Fim2.3, Fim3, and Fim2, respectively (Table 3) France, Germany, the Netherlands, Sweden, Denmark, and the United Kingdom, no isolate 155 presented PFGE patterns typical for strains circulating in Europe. As much as 70% of the 156
European isolates examined in the Hallander study (19) were assigned into 11 common PFGE 157 profiles with the most prevalent one as BpSR11, which belongs to the IVβ PFGE group. 158
BpSR11 comprised 10-50% of the isolates from Finland, France, Germany, the Netherlands, 159
Sweden, Denmark, and the United Kingdom (19). In Sweden, the increased frequency of 160 BpSR11 was to found to be related with more severe disease (3). 161
We found that only 47% of the Polish isolates studied belonged to PFGE groups III 162 and IV. PFGE group III contained B. pertussis strains isolated from all periods studied, all 163 three currently used vaccine strains and most of vaccine strains used historically for 164 production of the national whole-cell pertussis vaccine. One vaccine strain (1326/62) used in 165 previous periods for pertussis vaccine production was found in group IV. In contrast to the 166 strains from other European countries (7, 19, 43), the B. pertussis strains we studied were not 167 so commonly found in PFGE groups IVα, IVβ, and IVγ, as only seven, four and six isolates 168 were classified into groups IV α, IVβ and IVγ, respectively. In the three newly recognized 169 clusters, C, A, and B, 67 isolates (48%) were found. Cluster B, the most distinct one, 
